Drug Trial Radar · NCT06962956
Evaluating Gingivitis and Systemic Biomarkers
Last checked: Nov 20, 2026Latest source record: Nov 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
135
Actual
Start
Apr 30, 2025
Primary completion
Oct 31, 2025
Study completion Oct 31, 2025
Sponsor
- Lead sponsor
- Procter and GambleIndustry
- Sponsor type
- Industry
- First posted
- May 8, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (investigator, outcomes assessor)
- Primary purpose
- Basic science
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 25 years, up to 65 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This exploratory study will consist of two parts: Phase 1 (sample collection/screening) and Phase 2 (sample collection/product efficacy testing). The purpose of Phase 1 is to understand the association of gingivitis to systemic biomarkers and to screen subjects for Phase 2. The purpose of Phase 2 is to assess the causal effect of oral hygiene intervention on gingivitis and systemic biomarkers.
Conditions
- Gingivitis
Interventions
0.76% Sodium Monofluorophosphate DentifriceDrug
Brush two times a day for 1 minute with manual toothbrush
0.454% Stannous Fluoride DentifriceDrug
Brush two times a day for 1 minute with manual toothbrush
0.454% Stannous Fluoride DentifriceDrug
Brush two times a day for 2 minutes with electric toothbrush
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number Bleeding SitesTime frame: 4 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Salus Research
Fort Wayne, Indiana
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.